Psychotherapy

Field Trip Health & Wellness Ltd. Announces Launch of Online Therapy

Retrieved on: 
Thursday, January 12, 2023

TORONTO, Jan. 12, 2023 (GLOBE NEWSWIRE) -- Field Trip Health & Wellness Ltd. (TSX-V: FTHW) ("Field Trip" or the “Company”), a global leader in the delivery of psychedelic therapies, today launched Field Trip Online Therapy, a unique approach to psychotherapy that leverages contemporary talk therapy, integrative wellness tools and insights derived from being one of the largest global providers of psychedelic-assisted therapies.

Key Points: 
  • TORONTO, Jan. 12, 2023 (GLOBE NEWSWIRE) -- Field Trip Health & Wellness Ltd. (TSX-V: FTHW) ("Field Trip" or the “Company”), a global leader in the delivery of psychedelic therapies, today launched Field Trip Online Therapy, a unique approach to psychotherapy that leverages contemporary talk therapy, integrative wellness tools and insights derived from being one of the largest global providers of psychedelic-assisted therapies.
  • “We are delivering unparalleled mental health results for people who complete our ketamine-assisted therapy,” said Ronan Levy, Chairman and CEO of Field Trip.
  • That is why I’m thrilled to introduce our Field Trip Online Therapy program.
  • Field Trip Online Therapy is now available in New York with plans to roll out to additional states throughout 2023.

Telehealth Utilization Declined Nearly Four Percent Nationally in October 2022

Retrieved on: 
Tuesday, January 10, 2023

NEW YORK, Jan. 10, 2023 /PRNewswire/ -- In October 2022, after three months of relative stability, national telehealth utilization declined 3.7 percent, from 5.4 percent of medical claim lines in September to 5.2 percent in October, according to FAIR Health's Monthly Telehealth Regional Tracker.1 The decline in telehealth utilization was larger than the national average in the South (6.8 percent), Midwest (4.9 percent) and West (4.1 percent), while there was an increase in utilization of 1.7 percent in the Northeast. The data represent the privately insured population, including Medicare Advantage and excluding Medicare Fee-for-Service and Medicaid.

Key Points: 
  • In October 2022, COVID-19 continued to fall among the top five telehealth diagnoses nationally and in most regions, as it had in September.
  • Nationally and in the Midwest and South, it remained at second place but increased in percentage share of telehealth claim lines.
  • The rankings of the top five telehealth specialties did not change nationally or regionally from September to October 2022.
  • Nationally, the median charge amount for this service when rendered via telehealth was $126.20, and the median allowed amount was $77.70.3

Daytryp Health Announces Opening of Flagship Location in Phoenix, AZ

Retrieved on: 
Monday, January 9, 2023

PHOENIX, Jan. 9, 2023 /PRNewswire-PRWeb/ -- Daytryp Health, an up-and-coming psychedelic wellness center, announced today the opening of their first location in Phoenix, AZ. It is one of many locations that Daytryp is planning to open in 2023 and beyond. Located in the Arcadia neighborhood, the Phoenix location is the first Daytryp Health center to open this year, and will be followed by locations in Mesa, AZ and Bend, OR.

Key Points: 
  • Daytryp Health, an up-and-coming psychedelic wellness center, announced today the opening of their first location in Phoenix, AZ.
  • Located in the Arcadia neighborhood, the Phoenix location is the first Daytryp Health center to open this year, and will be followed by locations in Mesa, AZ and Bend, OR.
  • PHOENIX, Jan. 9, 2023 /PRNewswire-PRWeb/ -- Daytryp Health, an up-and-coming psychedelic wellness center, announced today the opening of their first location in Phoenix, AZ.
  • Located in the Arcadia neighborhood, the Phoenix location is the first Daytryp Health center to open this year, and will be followed by locations in Mesa, AZ and Bend, OR.

EQS-News: Reset Pharmaceuticals Appoints Innes Meldrum as President and Chief Executive Officer

Retrieved on: 
Sunday, January 22, 2023

New York, NY, January 5, 2023 - Reset Pharmaceuticals, Inc. (Reset Pharma), a privately held biotechnology company focused on the development of innovative treatments to address mental health indications related to life-altering diseases, today announces that Innes Meldrum has been appointed President and Chief Executive Officer.

Key Points: 
  • New York, NY, January 5, 2023 - Reset Pharmaceuticals, Inc. (Reset Pharma), a privately held biotechnology company focused on the development of innovative treatments to address mental health indications related to life-altering diseases, today announces that Innes Meldrum has been appointed President and Chief Executive Officer.
  • Innes Meldrum has nearly 30 years of global experience in the biotechnology and technology industries, having most recently served as Senior Vice President and Chief Commercial Officer for Otsuka Pharmaceuticals North America.
  • “We are delighted to have Innes join Reset Pharma as CEO,” said Philip Taub, Chair of the Board.
  • I warmly welcome Innes and look forward to working with him and the entire Reset Pharma team.

Reset Pharmaceuticals Appoints Innes Meldrum as President and Chief Executive Officer

Retrieved on: 
Thursday, January 5, 2023

NEW YORK, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Reset Pharmaceuticals, Inc. (Reset Pharma), a privately held biotechnology company focused on the development of innovative treatments to address mental health indications related to life-altering diseases, today announces that Innes Meldrum has been appointed President and Chief Executive Officer.

Key Points: 
  • NEW YORK, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Reset Pharmaceuticals, Inc. (Reset Pharma), a privately held biotechnology company focused on the development of innovative treatments to address mental health indications related to life-altering diseases, today announces that Innes Meldrum has been appointed President and Chief Executive Officer.
  • Innes Meldrum has nearly 30 years of global experience in the biotechnology and technology industries, having most recently served as Senior Vice President and Chief Commercial Officer for Otsuka Pharmaceuticals North America.
  • “We are delighted to have Innes join Reset Pharma as CEO,” said Philip Taub, Chair of the Board.
  • I warmly welcome Innes and look forward to working with him and the entire Reset Pharma team.

CAMFT Celebrates Legislation to Include Marriage & Family Therapists in Medicare

Retrieved on: 
Friday, December 23, 2022

SAN DIEGO, Dec. 23, 2022 (GLOBE NEWSWIRE) -- The California Association of Marriage and Family Therapists (CAMFT) is celebrating the momentous passage of the Mental Health Access Improvement Act within the Omnibus bill, which includes Marriage and Family Therapists (MFTs) as Medicare providers.

Key Points: 
  • SAN DIEGO, Dec. 23, 2022 (GLOBE NEWSWIRE) -- The California Association of Marriage and Family Therapists (CAMFT) is celebrating the momentous passage of the Mental Health Access Improvement Act within the Omnibus bill, which includes Marriage and Family Therapists (MFTs) as Medicare providers.
  • "Access to mental health services is vital to the health and well-being of our communities, and without Marriage and Family Therapists, these services would be limited," said Representative Mike Thompson.
  • "I am proud that my legislation to make Medicare cover mental health services provided by counselors and Marriage and Family Therapists was included in the government funding bill.
  • This legislation will add over 200,000 mental health clinicians to the Medicare workforce, allowing increased access to desperately needed mental healthcare.

Rany T. Abdallah, MD, Ph.D., is recognized by Continental Who's Who

Retrieved on: 
Wednesday, January 4, 2023

Dr. Abdallah earned his medical degree and Doctor of Philosophy degree (Ph.D.) at the Medical University of South Carolina.

Key Points: 
  • Dr. Abdallah earned his medical degree and Doctor of Philosophy degree (Ph.D.) at the Medical University of South Carolina.
  • Dr. Abdallah is the Owner/President of APICO Pain Management, serving patients in the Bear, Dover, and Millsboro areas.
  • A pain management specialist is a doctor who specializes in pain medicine, focusing on the evaluation, treatment, and prevention of pain.
  • In his free time, Dr. Abdallah likes to travel and is fluent in English, Arabic, French, and Spanish.

Montana Psychiatry & Brain Health Center Expands Access to Mental Health Care in Bozeman

Retrieved on: 
Monday, December 19, 2022

Montana Psychiatry & Brain Health Center (Montana Psychiatry), a leading provider of psychiatric services and member of Turnwell Mental Health Network, announced today the company is expanding access to local, cutting-edge, physician-led treatment with a new outpatient mental health treatment clinic in Bozeman, MT.

Key Points: 
  • Montana Psychiatry & Brain Health Center (Montana Psychiatry), a leading provider of psychiatric services and member of Turnwell Mental Health Network, announced today the company is expanding access to local, cutting-edge, physician-led treatment with a new outpatient mental health treatment clinic in Bozeman, MT.
  • According to the National Alliance on Mental Illness, there are over 163,000 adults in Montana who have a mental health condition.
  • In Montana, like much of the US, over half of the individuals struggling with mental illness did not receive needed mental health care over the last year.
  • Turnwell Mental Health Network is a clinician-led, integrated mental health group specializing in local and affordable care for individuals suffering from mental health disorders with a mission to expand access to high-quality care in underserved markets.

Telehealth An Effective Way To Treat Opioid-Use Disorder And Increase Access To Care, According To Peer-Reviewed Study From Bicycle Health

Retrieved on: 
Thursday, December 15, 2022

A summary of the key outcomes and insights from the research are available online here in Bicycle Health’s resource center for strategic partners.

Key Points: 
  • A summary of the key outcomes and insights from the research are available online here in Bicycle Health’s resource center for strategic partners.
  • This is higher than the industry average, which is 44% at 90 days.
  • Approximately 70% of new Bicycle Health patients are seen by a buprenorphine-waivered provider on the same or next business day as their initial enrollment outreach.
  • It is a collaboration between BMJ and the All India Institute of Medical Sciences (AIIMS).

Anavex Strengthens Scientific Advisory Board with Investigator from Phase 2b/3 Alzheimer’s Trial

Retrieved on: 
Wednesday, December 14, 2022

Prof. Dr. Grimmer served as National Coordinating Investigator for the ANAVEX®2-73 (blarcamesine) Phase 2b/3 ANAVEX®2-73-AD-004 study.

Key Points: 
  • Prof. Dr. Grimmer served as National Coordinating Investigator for the ANAVEX®2-73 (blarcamesine) Phase 2b/3 ANAVEX®2-73-AD-004 study.
  • The main focus of Prof. Dr. Grimmer’s research is assessing the usefulness of biomarkers in predicting neurocognitive disorders.
  • In addition, he has served as a national coordinating investigator and as a principal investigator in more than 70 drug trials including all monoclonal antibodies against cerebral amyloid load.
  • “I’m excited to join Anavex’s Scientific Advisory Board at this time of important growth and evolution of the Company,” said Professor Dr. Grimmer.